News

New iron-based imaging agent offers significantly improved visualization of brain tumors

Ferumoxytol is an iron-based substance that is used primarily in medications that treat anemia. However, the FDA recently cleared it for use in brain imaging as well.

AI tool reduces readers' kidney lesion interpretation times by over 30%

The tool also can be used on contrasted abdominal scans completed for other clinical indications, offering providers an opportunity to address suspicious lesions before they progress.

High-level briefing: Regional merger scrapped | Provider chain denied | Holiday inspiration appreciated | more

The biggest investor in a nursing home chain can run but not hide from comeuppance for the chain’s alleged role in harms—including deaths—done to hundreds of patients.

FDA approves new drug for genetic heart disease

Cytokinetics has secured FDA approval for aficamten, its new drug for the treatment of symptomatic obstructive HCM. Aficamten will be sold under the brand name Myqorzo.

A diabetic foot ulcer that does not heal due to low blood supply from peripheral artery disease (PAD), and the before and after interventional angiograms of the patient's revascularization treatment. Images courtesy of Foluso Fakorede, MD

ACC calls for better management of peripheral artery disease in diabetic patients

PAD in patients with diabetes is common and associated with an increased risk of several adverse events. A new guidance from the American College of Cardiology reviewed this topic at length, identifying areas where care needs to improve.

Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.

SCAI town hall addresses workforce concerns in interventional cardiology

One of the event's primary takeaways was that interventional cardiology does still attract a healthy number of trainees. However, SCAI sees several ways the specialty can improve to be even more appealing in the future.

heart data research doctor cardiologist AI

New PFA registry will use AI, EHR integration to gather real-world data

PFA has emerged as the preferred ablation strategy for many electrophysiologists, but some questions do remain about its long-term impact. HRS is developing this new registry to be as user-friendly for clinicians as possible.

Kimberly Powell, vice president, general manager of healthcare at NVIDIA, explains how artificial intelligence (AI) has rapidly expanded in radiology and how many of the companies showing AI products at the Radiological Society of North America (RSNA) 2025 meeting use the company's technology. She said a few key technology launches by GE Healthcare show a deeper integration of NVIDIA's AI technology, and shared what the next generation of "physical AI" will enable autonomous radiology exams.

NVIDIA sees major shift in radiology to AI agents and new autonomous imaging systems

“Physical AI agents being able to actually deliver some of these services—all the way into robotic surgery—this is where we're going to see this next chapter of medicine be written,” said Kimberly Powell, vice president and general manager of healthcare at NVIDIA.

Generative AI increases efficiency, quality of radiology reports

Experts note that multimodal GenAI presents a “transformative opportunity” to increase the efficiency and accuracy of radiologist reporting.

3D imaging reveals details of cranial bone aging

A group of researchers used 3D imaging to examine changes in the skulls of mice as they age, revealing a new perspective on how older bones heal.

Family files lawsuit after transplant ends in tragedy—says son ‘got the heart of a meth addict’

A Florida family is suing Mayo Clinic for allegedly performing a heart transplant without communicating certain risks associated with the donated organ. Mayo Clinic has pushed back against those claims, saying it acted appropriately every step of the way.

Blood tests for signs of organ rejection made available for young heart transplant patients

The donor-derived cell-free DNA tests from CareDx are designed to limit the use of surveillance biopsies and other more invasive treatment options. These tests have been available for adult patients for years now.

Around the web

Radiology Business